CLDN18.2 May Define Lung Adenocarcinoma Phenotype - Poll - MDSpire

CLDN18.2 May Define Lung Adenocarcinoma Phenotype

Frequent CLDN18.2 expression was associated with gastric-type differentiation and reduced spread through air spaces in pulmonary invasive mucinous adenocarcinoma.

  • By

  • Andrea Surnit

  • July 22, 2026

  • 3 min

Share

Original Source(s)

CLDN18.2 May Define Lung Adenocarcinoma Phenotype

  • by Andrea Surnit

  • July 22, 2026

Related Content

AI Model Differentiates BCC vs cSCC Subtypes

External validation identifies calibration shift in COBRA cohort.

Can Proteomics Refine Lung Screening?

Proteomic biomarkers improve short-term lung cancer risk assessment.

AI Outperforms MDs on Reasoning Tasks

Across six experiments—including a blinded, real-world ER evaluation—an OpenAI large language model outperformed physician baselines on multiple clinical reasoning tasks, though not on key safety endpoints such as cannot-miss diagnoses